Get the Stockscreener App
3.325
2.20%
-0.085
Sana Biotechnology Inc stock is traded at $3.325, with a volume of 1.12M.
It is down -2.20% in the last 24 hours and down -0.45% over the past month.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.
See More
Previous Close:
$3.41
Open:
$3.395
24h Volume:
1.12M
Relative Volume:
0.22
Market Cap:
$794.27M
Revenue:
-
Net Income/Loss:
$-252.18M
P/E Ratio:
-3.1368
EPS:
-1.06
Net Cash Flow:
$-185.29M
1W Performance:
+1.37%
1M Performance:
-0.45%
6M Performance:
+55.12%
1Y Performance:
-11.30%
1-Day Range:
$3.3107
$3.43
1-Week Range:
$2.93
$3.58
52-Week Range:
$1.26
$7.30
Sana Biotechnology Inc Stock (SANA) Company Profile
Name
Sana Biotechnology Inc
Sector
Industry
Phone
(206) 701-7914
Address
188 EAST BLAINE STREET, SUITE 400, SEATTLE
Compare SANA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SANA
Sana Biotechnology Inc
|
3.34 | 877.22M | 0 | -252.18M | -185.29M | -1.06 |
|
VRTX
Vertex Pharmaceuticals Inc
|
380.00 | 96.56B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.56 | 60.08B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.68 | 61.15B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
711.63 | 44.66B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
328.11 | 36.23B | 3.81B | -644.79M | -669.77M | -6.24 |
Sana Biotechnology Inc Stock (SANA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-03-25 | Resumed | Morgan Stanley | Overweight |
| Mar-18-25 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Mar-14-25 | Initiated | Jefferies | Buy |
| Jan-08-25 | Upgrade | TD Cowen | Hold → Buy |
| Nov-05-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Jun-26-24 | Initiated | Rodman & Renshaw | Buy |
| Jan-16-24 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Sep-25-23 | Initiated | JMP Securities | Mkt Outperform |
| Sep-05-23 | Initiated | Citigroup | Buy |
| Aug-14-23 | Initiated | TD Cowen | Market Perform |
| May-02-23 | Initiated | H.C. Wainwright | Neutral |
| Mar-01-21 | Initiated | BofA Securities | Buy |
| Mar-01-21 | Initiated | Goldman | Neutral |
| Mar-01-21 | Initiated | JP Morgan | Neutral |
| Mar-01-21 | Initiated | Morgan Stanley | Overweight |
View All
Sana Biotechnology Inc Stock (SANA) Latest News
Wedbush Initiates Coverage of Sana Biotechnology (SANA) with Outperform Recommendation - Nasdaq
SANA: Wedbush Initiates Coverage with 'Outperform' Rating | SANA Stock News - GuruFocus
Sana Biotechnology Has Long-Term Growth Potential on Diabetes, CAR-T Therapies, Wedbush Says - MarketScreener
Sana Biotechnology (NASDAQ:SANA) Earns Outperform Rating from Analysts at Wedbush - MarketBeat
Wedbush Initiates Sana Biotechnology at Outperform With $5 Price Target - MarketScreener
Bothell loses planned biotechnology manufacturing plant - Everett Herald
Sana Biotechnology, Inc. $SANA Shares Sold by Goldman Sachs Group Inc. - MarketBeat
Sana Biotechnology (NASDAQ:SANA) Trading Up 9%Time to Buy? - MarketBeat
Can Sana Biotechnology’s (SANA) Pipeline Momentum Translate into More Share Price Upside? - MSN
Earnings Risk: Is Sana Biotechnology Inc a stock for growth or value investorsWeekly Volume Report & Trade Opportunity Analysis - خودرو بانک
Sana Biotechnology Inc. (SANA) Bolsters Management Team - Yahoo Finance
Aug Reactions: Should value investors consider Hamilton Lane IncorporatedWeekly Gains Summary & Low Drawdown Momentum Trade Ideas - khodrobank.com
Insider Trends: What are Sana Biotechnology Incs earnings expectationsPortfolio Gains Report & Safe Entry Trade Signal Reports - khodrobank.com
Sentiment Watch: Is Sana Biotechnology Inc. in a long term uptrendQuarterly Market Summary & Daily Market Momentum Tracking - خودرو بانک
Movement Recap: Is Sana Biotechnology Inc stock a hidden gemTrade Entry Summary & Growth Oriented Trade Recommendations - khodrobank.com
SCS Capital Management LLC Takes Position in Sana Biotechnology, Inc. $SANA - MarketBeat
Aug Update: Is Sana Biotechnology Inc. a strong candidate for buy and holdWeekly Trend Summary & Smart Investment Allocation Insights - khodrobank.com
Breakout Zone: Can Sana Biotechnology Inc. scale operations efficientlyEarnings Growth Summary & Risk Managed Investment Strategies - khodrobank.com
Ideas Watch: Is Sana Biotechnology Inc benefiting from interest rate changesJuly 2025 Spike Watch & Smart Investment Allocation Insights - خودرو بانک
US Market Recap: Should value investors consider Siddhi Acquisition Corp. Debt Equity Composite UnitsTrend Reversal & Free Expert Approved Momentum Trade Ideas - khodrobank.com
Growth Recap: What’s Sana Biotechnology Inc.’s historical returnSell Signal & Weekly Top Gainers Alerts - خودرو بانک
Investment Review: Is Sana Biotechnology Inc stock trending bullish2025 Price Targets & Risk Controlled Daily Trade Plans - خودرو بانک
What’s Sana Biotechnology Inc.’s historical return2025 Price Action Summary & Growth Focused Entry Reports - خودرو بانک
Sentiment Review: Is Sana Biotechnology Inc a stock for growth or value investorsWeekly Market Report & Consistent Growth Equity Picks - خودرو بانک
Update Recap: Will Vontier Corporation benefit from geopolitical trends2025 Growth vs Value & Weekly Top Gainers Alerts - خودرو بانک
Sana Biotechnology (NASDAQ:SANA) Trading Down 6%Here's Why - MarketBeat
Citizens JMP Reiterates a Buy Rating on Sana Biotechnology (SANA) With a $5 PT - MSN
Can Sana Biotechnology Inc be the next market leader2025 Risk Factors & High Conviction Buy Zone Picks - خودرو بانک
Market Overview: Is SERV stock a value trapJuly 2025 Short Interest & Verified Technical Signals - خودرو بانک
Breakout Move: Is Sana Biotechnology Inc. stock trending bullish2025 Geopolitical Influence & Short-Term High Return Ideas - خودرو بانک
Aug EndMonth: Is Sana Biotechnology Inc in a long term uptrendQuarterly Trade Summary & Expert Approved Momentum Ideas - خودرو بانک
Sana Biotechnology (NASDAQ:SANA) Trading Up 10.1%What's Next? - MarketBeat
3 Stocks to Buy Under $10 That Could Triple From Here - Yahoo Finance
Is a relief rally coming for Sana Biotechnology Inc. holdersTreasury Yields & Fast Entry High Yield Stock Tips - newser.com
410,535 Shares in Sana Biotechnology, Inc. $SANA Acquired by Clearline Capital LP - MarketBeat
Invesco Ltd. Has $278,000 Stock Holdings in Sana Biotechnology, Inc. $SANA - MarketBeat
Ieq Capital LLC Raises Stock Holdings in Sana Biotechnology, Inc. $SANA - MarketBeat
Vident Advisory LLC Boosts Holdings in Sana Biotechnology, Inc. $SANA - Defense World
Sana Biotechnology, Inc. (NASDAQ:SANA) Given Average Rating of "Buy" by Brokerages - MarketBeat
Rafferty Asset Management LLC Reduces Stock Position in Sana Biotechnology, Inc. $SANA - MarketBeat
Can Sana Biotechnology Inc. be the next market leaderQuarterly Investment Review & Safe Capital Growth Stock Tips - Lancaster City Council
Can CRISPR Finally Cure Type 1 Diabetes for Good? - Securities.io
Nuveen LLC Makes New Investment in Sana Biotechnology, Inc. $SANA - MarketBeat
Sana Biotechnology Inc. Outperforms Peers on Volume Metrics2025 Biggest Moves & Verified Short-Term Plans - beatles.ru
JMP Securities Keeps Market Outperform Rating on Sana Biotechnology (SANA) - Insider Monkey
Sana Biotechnology, Inc. $SANA Shares Acquired by Hsbc Holdings PLC - Defense World
Sana Biotechnology Inc Stock (SANA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Sana Biotechnology Inc Stock (SANA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Cassidy Bernard J | EVP & General Counsel |
Mar 07 '25 |
Option Exercise |
0.00 |
11,041 |
0 |
115,823 |
| Harr Steve | President & CEO |
Mar 07 '25 |
Option Exercise |
0.00 |
50,000 |
0 |
7,889,750 |
| Wyrick Susan D. | See Remarks |
Mar 02 '25 |
Option Exercise |
0.00 |
1,525 |
0 |
155,471 |
2.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):